LAB
Standard BioTools, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.62
+0.85%Margins
Gross margin
50.8%
EBITDA margin
-96.9%
EBIT margin
-90.6%
Net margin
-46.4%
FCF margin
-77.8%
-7.1%
Return on equity
-6.2%
Return on assets
-13.1%
Return on invested capital
0.13x
Asset turnover
-$64.3M
Cash from operations
$1.17
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026